Acquired haemophilia A in a patient with chronic hepatitis C virus infection receiving treatment with pegylated interferon plus ribavirin: role of rituximab M. Á. Fernández de Palencia Espinosa, V. Arocas Casañ, B. Garrido Corro, A. de la Rubia Nieto

Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice Chovi-Trull, Megias-Vericat, Santiago Bonanad Boix, Saturnino Haya Guaita, Ana Rosa Cid Haro, Marta Aguilar Rodriguez, Andres

Cost-effectiveness of drug therapy prescribed in special situations at hospital Gonzalo González-Morcillo, Beatriz Calderón-Hernanz, Juan Manuel Rodríguez-Camacho